This site uses cookies to bring you the best experience. Find out more
Skip to main content

SECURITIES INFORMATION

 

NUMBER OF AIM SECURITIES IN ISSUE

The number of shares in issue is 803,362,994.

SIGNIFICANT SHAREHOLDERS

Significant shareholders of Eden Research plc are:

Name

Number of shares

% of the issued ordinary share capital

Gresham House Asset Management Limited

 

177,882,786 

22.14%

Octopus Investments 

 

91,551,047

11.40%

Canaccord Wealth 

67,776,307

8.44%

 

Hargreaves Lansdown 

 

62,191,876

7.74%

Unicorn Asset Management  

60,576,923

 

7.54%

 

Interactive Investor

 

46,764,568

5.82%

Sipcam Oxon S.p.A.

 

39,285,138

4.89%

Atul Unadkat

 

33,047,220

4.11%

Rathbones 

 

25,910,109

3.23%

Maven Capital Partners 

 

24,843,457

3.09%

Directors' shareholdings in the share capital of Eden Research plc are:

Name

Number of shares

% of the issued ordinary share capital

A Abrey                                                                 

 

3,681,678

0.60%

S Smith

 

3,559,768

0.58%

L van der Broek

 

3,482,808

0.56%

D McAllan

 

1,093,627

0.17%

R Cridland

745,552

0.12%

 

SHARES NOT IN PUBLIC HANDS

In the terms of AIM Rules published July 2016 and insofar as it is aware, at 8 September 2026, 26.41% of the Company's AIM securities was not in public hands.

RESTRICTION IN TRANSFER OF AIM SECURITIES

There are no restrictions on the transfer of Eden Research Plc's AIM securities.

DETAILS OF ANY OTHER EXCHANGES AND TRADING PLATFORMS

Eden Research Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.

UK CITY CODE ON TAKEOVERS AND MERGERS

As an AIM traded UK registered company, Eden Research plc is subject to the UK City Code on Takeovers and Mergers legislation.

 

The Information above was lasted updated on 8 September 2026